Extracorporeal Membrane Oxygenation Machine (ECMO) Market to Reach $793.7 Million, Globally, by 2033 at 4.6% CAGR: Allied Market Research

The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing growth due to the rise in the incidence of chronic diseases especially cardiac disease, and increase in focus of the key players toward innovative extracorporeal membrane oxygenation (ECMO) machine technologies which are expected to drive the growth of the market. 

WILMINGTON, Del., Aug. 20, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Extracorporeal Membrane Oxygenation Machine (ECMO) Market by Type (Veno-arterial, Veno-venous and Others), Components (Pumps, Oxygenator, Controllers and Others), and Application (Adult, Pediatric and Neonates): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is estimated to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033. 

Request Sample of the Report on Extracorporeal Membrane Oxygenation Machine (ECMO) Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A284556 

Prime determinants of growth 

The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing growth due to several factors such as an increase in the prevalence of severe respiratory diseases, including pneumonia, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS) . Modern life support systems have become essential due to the rising incidence of heart failure, myocardial infarction, and other cardiovascular diseases. In addition, there are constant advancements in ECMO technology, such as better pumps, sophisticated monitoring systems, and oxygenators that are both biocompatible and efficient. Furthermore, development of portable and compact ECMO machines that can be used in various settings, including during patient transport and in field hospitals are driving the market growth. 

Report coverage & details: 

Have a Question? Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A284556 

Segment Highlights 

Increasing utilization of oxygenators 

The oxygenator is a crucial component of Extracorporeal Membrane Oxygenation (ECMO) machines, serving as an artificial lung to facilitate gas exchange. Advances in design have resulted in smaller, more portable oxygenators, facilitating easier transport of ECMO patients within and between healthcare facilities without interrupting life support. In addition, development for enhancing the surface area and optimizing the flow dynamics within oxygenators improve oxygen and carbon dioxide transfer rates, crucial for patient stability during ECMO therapy. 

Rise in adoption of Arterio-Venous machine 

Arterio-Venous Extracorporeal Membrane Oxygenation (A-V ECMO) machines provide several advantages in critical care, especially for patients with severe cardiac and respiratory failure. A-V ECMO can be simpler to implement than other types because it typically doesn't require cannulation of both a major vein and artery. It might be less invasive since other types involves arterial cannulation, which can be more technically challenging and carries higher risks of complications like limb ischemia. 

Adult segment to dominate the market in 2033 

The demand for extracorporeal membrane oxygenation (ECMO) machine is expected to rise as adults are more likely to suffer from severe respiratory conditions. In addition, the prevalence of heart failure, myocardial infarction, and other cardiovascular diseases is higher in the adult population, driving the demand for ECMO as a life-saving intervention. The aging global population, which is more susceptible to severe cardiopulmonary conditions, significantly contributes to the demand for ECMO in the adult segment. Moreover, the increasing geriatric population, is at higher risk for diseases that necessitate ECMO support, such as severe pneumonia, heart failure, and chronic respiratory conditions. 

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A284556 

Regional Outlook 

By region, North America held the largest market share in the terms of revenue in 2023, the global extracorporeal membrane oxygenation (ECMO) machine market revenue, and is likely to dominate the market during the forecast period. This is attributed to its advanced technology infrastructure, strong demand & availability of extracorporeal membrane oxygenation (ECMO) machine, and availability of well-developed healthcare facilities. 

However, the Asia-Pacific region is expected to witness rapid industrialization in countries like China and India which has led to the establishment and advancements and accessibility of such machines. A surge in the geriatric population, increase in the prevalence of cardiac diseases, and increase in healthcare expenditure are expected to lead to the growth of the market. Significant investments in healthcare infrastructure, especially in developing regions, are leading to the establishment of advanced critical care units equipped with ECMO machines, primarily serving adult patients. 

Key Players:

• Medtronic PLC
• Sorin Group
• Terumo Corporation
• MAQUET Holding
• Nipro Medical Corporation
• Microport Scientific Corporation
• Medos Medizintechnik AG
• Getinge AB
• Livanova PLC
• Fresnius Medical Care

The report provides a detailed analysis of these key players in the global extracorporeal membrane oxygenation (ECMO) machine market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Recent Developments

• In October 2021, Getinge launched the Rotaflow II extracorporeal life support system. The system, together with the Permanent Life Support (PLS) Set, offers up to 14 days of cardiopulmonary support in a compact, portable, safe, and reliable manner. 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

SOURCE Allied Market Research